Overall rank by patents
#36,183
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 3 technology areas, active 2017–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A47C (CHAIRS; SOFAS; BEDS).
The verdict
Leggett holds 7 US patents across 3 technology areas, rank #36,183 of 50,000 tracked assignees.
Leggett & Platt, Inc. has been granted 7 US utility patents between 2017 and 2022, placing Leggett & Platt, Inc. at rank #36,183 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in A47C (CHAIRS; SOFAS; BEDS). As a US Corporation, Leggett & Platt, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Leggett sits between LEAD Pharma Holding B.v. (7 patents, rank #36,179) and Lenlok Holdings Llc (7 patents, rank #36,187) - the closest US assignees by grant volume. The composite Innovation Score of 42.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 2 in the 2015–2019 window, a +150% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Leggett & Platt, Inc.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Leggett & Platt, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
LEAD PHARMA HOLDING B.V.
7 patents
LECTRA
7 patents
LED INSPIRATIONS LLC
7 patents
LED iBond International A/S
7 patents
LEICHTBAU-ZENTRUM SACHSEN GMBH
7 patents
LEITH MEDICAL, LLC
7 patents
LEMER PAX
7 patents
LENLOK HOLDINGS LLC
7 patents
LEGGETT & PLATT, INC.
7 patents
What this shows Leggett holds 7 patents at rank #36,183, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #36,183 in granted patent volume.
Other assignees with the most granted patents in Leggett's primary technology class.
Leggett's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
42 Top 31% higher than 69% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 14.3% |
| 2018 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2022 | 4 | 57.1% |
Top 3 of 3 technology areas
Overall rank by patents
#36,183
Across all tracked assignees
42.0 out of 100
How to use this portfolio
Leggett's 7 grants land it in the top 31% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.